Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year
In a retrospective study, researchers analyzed the number of acne vulgaris diagnoses among people with obesity but not diabetes who had been prescribed Saxenda (liraglutide), Wegovy (semaglutide), or Zepbound (tirzepatide)
Einige Hersteller bieten auch Nasensprays oder Sublingualtabletten an, die die Schleimhute umgehen sollen
Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population
Augmenting NAD(+) may combat kidney stress
Theyre smaller in molecular weight than peptide medications that mimic or interfere with endogenous bioregulatory peptides. Think of it this way: While a peptide is like a fragile piece of paper that dissolves in the rain, a small molecule is like a tiny pebble, sturdy enough to survive the digestive storm